Prelude Therapeutics (PRLD) PT Lowered to $5 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts PRLD Hot Sheet
Price: $6.63 +2.00%
Rating Summary:
4 Buy, 1 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
4 Buy, 1 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
H.C. Wainwright analyst Robert Burns lowered the price target on Prelude Therapeutics (NASDAQ: PRLD) to $5.00 (from $6.00) while maintaining a Buy rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
- MidCap Financial Investment Corp (MFIC) PT Lowered to $9.50 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
